TSE:L

Loblaw Companies Ltd (L.TO)

62.80
+1.18 (1.91%)
as of Jun 3, 2026, 8:00:00 pm Market Open.
321 watching
0
Investor Insights
star iconJun 3, 2026, 12:00 am

This summary was created by AI, based on 15 opinions in the last 12 months.

Loblaw Companies Ltd is the largest food and drug retailer in Canada, benefiting from its dominant market position, especially through strong private labels like No Name and the successful acquisition of Shoppers Drug Mart (SDM). The company has shown resilience amid inflation and rising costs, which have led to an increase in food prices, yet its focus on discount banners is resonating well with consumers seeking value. Analysts believe there's strong growth potential, particularly due to SDM's market share in pharmaceuticals and grocery. However, some experts caution that the stock is reaching its highest valuations in years, presenting a potential issue for future growth sustainability. While the technical aspects of the stock are favorable, there are concerns regarding competition from giants like Walmart and Costco, impacting its attractiveness at this valuation level.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Overvalued
review icon
Similar
Costco, COST
PAST TOP PICK
(A Top Pick Jul 09/21, Up 20%) Trading in and out of this stock. Has pulled out of Loblaws when they were seeing key technical resistance. The yoy comparisons will become more challenging when we get to the third and fourth quarter. Does not own it currently. Would trim back.
BUY
Strong point is ownership of Shoppers. Way cheaper for healthcare to deliver vaccines through pharmacies. Supply chain and IT issues fixed. A tough space. A growth market due to immigration. Not cheap, but opportunities for growing earnings and dividends.
TOP PICK
Digital and e-commerce transition. Cheap relative to its space and on an absolute basis. Having Shoppers as an asset is so powerful. Yield is 1.9%. (Analysts’ price target is $75.33)
DON'T BUY

Grocery business is extremely competitive. He'd rather focus on Costco, Walmart, Amazon through Whole Foods. Private label investment putting pressure on margins plus its unionized workforce have been headwinds. 15x earnings for a 5% growth rate is not compelling at this part of the cycle.

HOLD
Suffered in Q3 last year with the reopening. High quality. A mature sector, disruption is always coming from e-commerce. Valuation is not that expensive at 13x. Intense competition. A hold.
BUY

He just added to his position around $62. He doesn't understand how it fell that low. It's a great business and enjoys an oligopoly in Canada. They reached same-store sales growth last year that will likely taper off as people eat in restaurants more. Food inflation will benefit the grocers. It's in a stable, safe business. The PE is fair. Empire has performed the best in this group, while Metro is managed well and steady. Loblaw has lagged, but is the most undervalued and offers the best value.

HOLD

WN-T vs. L-T This sector is just not loved right now. Investors just aren't looking at these kinds of stocks right now. Their costs have been moving up but people aren't eating more. Their sweet spot is late April until late May. L-T could be okay so he would hold on to it.

BUY
The valuation is so cheap relative to the rest of the market. He thinks these guys are positioned well in a lot of ways. It is a low margin business but it is a great safe place to own and he would add to the name.
PAST TOP PICK
(A Top Pick Jan 14/20, Down 2%) It has lagged the market. The valuation is very attractive. Food retail is very competitive. They incurred incremental costs for PPE and had to pay higher wages. They own Shoppers Drug Mart but their front end of their stores really weakened because of working from home. Money shifted away and now she finds it very attractive.
BUY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. A nice stable stock with a secure dividend. Although it may only show slow growth, it is a defensive play in case of volatility and downturn. Unlock Premium - Try 5i Free

DON'T BUY

Stock's underperformed for a while. Prefers Costco to all the food retailers. Not a big buyer of consumer staples right now. In a recovery, you want to focus on cyclicals. Covid costs have hit grocery stores.

BUY

L vs. WN A bit like splitting hairs. Weston controls Loblaw. When you buy Weston, you get 95% Loblaw and 5% bakery. A great business. A buy and hold through the cycles. If you get a rip roaring cyclical market, it will probably lag. High single digit or low double digit return. He doesn't like the bakery, so Loblaw gets the nod.

HOLD

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The stock remains at a lower range. Investors may believe it has benefited strongly from the pandemic, thus future growth will be slower than recent growth. It is still a solid company and decent investment. Likes it for safety, stability and some growth. Unlock Premium - Try 5i Free

SELL

Trading in a jittery way for some years. Has let go technical support of $70. Makes him nervous. He's switch to Weston, as that's near its 10-year valuation low, with good upside potential. Weston is safer.

BUY
On strike in Newfoundland for the past month A steady business and doing well during Covid. Loblaw also owns pharmacies. It's reasonably priced in the high-$60s.
Showing 61 to 75 of 706 entries